AMGN vs NBIX
Amgen Inc. and Neurocrine Biosciences Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | AMGN | NBIX |
|---|---|---|
| Revenue | $36.8B | $2.9B |
| Net income | $7.7B | $478.6M |
| Gross margin | 67.2% | 98.2% |
| Net margin | 21.0% | 16.7% |
| Return on equity | 106.1% | 16.4% |
| Diluted EPS | $14.23 | $4.67 |
| Dividend / share | $9.66 | · |
| Payout ratio | 66.5% | · |
| Free cash flow | $8.1B | $748.7M |
| Equity | $8.7B | $3.3B |
| Net debt / equity | 5.25× | · |
| Current ratio | 1.14× | 3.39× |
| Revenue CAGR 5y | 7.6% | 22.3% |
| Profit CAGR 5y | 1.2% | 3.3% |
AMGN bills 12.8× the revenue of NBIX, and keeps more of each dollar of revenue as profit (21.0% against 16.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | AMGN | NBIX |
|---|---|---|
| FY2025 | $36.8B | $2.9B |
| FY2024 | $33.4B | $2.4B |
| FY2023 | $28.2B | $1.9B |
| FY2022 | $26.3B | $1.5B |
| FY2021 | $26.0B | $1.1B |
| FY2020 | $25.4B | $1.0B |
| FY2019 | $23.4B | $788.1M |
| FY2018 | $23.7B | $451.2M |
| FY2017 | $22.8B | $161.6M |
| FY2016 | $23.0B | $15.0M |
Bottom line
| Fiscal year | AMGN | NBIX |
|---|---|---|
| FY2025 | $7.7B | $478.6M |
| FY2024 | $4.1B | $341.3M |
| FY2023 | $6.7B | $249.7M |
| FY2022 | $6.6B | $154.5M |
| FY2021 | $5.9B | $89.6M |
| FY2020 | $7.3B | $407.3M |
| FY2019 | $7.8B | $37.0M |
| FY2018 | $8.4B | $21.1M |
| FY2017 | $2.0B | $-142.5M |
| FY2016 | $7.7B | $-141.1M |
17 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$33,890,500,000 | AMGN |
| FY2024 | +$31,068,700,000 | AMGN |
| FY2023 | +$26,302,900,000 | AMGN |
| FY2022 | +$24,834,300,000 | AMGN |
| FY2021 | +$24,845,500,000 | AMGN |
| FY2020 | +$24,378,100,000 | AMGN |
| FY2019 | +$22,573,900,000 | AMGN |
| FY2018 | +$23,295,800,000 | AMGN |
| FY2017 | +$22,687,374,000 | AMGN |
| FY2016 | +$22,976,000,000 | AMGN |
| FY2015 | +$21,642,231,000 | AMGN |
| FY2014 | +$20,063,000,000 | AMGN |
| FY2013 | +$18,673,081,000 | AMGN |
| FY2012 | +$17,211,860,000 | AMGN |
| FY2011 | +$15,504,587,000 | AMGN |
| FY2010 | +$15,019,499,000 | AMGN |
| FY2009 | +$14,639,047,000 | AMGN |
AMGN has reported the higher revenue in every one of these 17 fiscal years. The gap has widened since the earliest year compared.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
14 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +4.3 pp | AMGN |
| FY2024 | −2.3 pp | NBIX |
| FY2023 | +10.6 pp | AMGN |
| FY2022 | +14.5 pp | AMGN |
| FY2021 | +14.8 pp | AMGN |
| FY2020 | −10.4 pp | NBIX |
| FY2019 | +28.9 pp | AMGN |
| FY2018 | +30.7 pp | AMGN |
| FY2017 | +96.9 pp | AMGN |
| FY2016 | +974.2 pp | AMGN |
| FY2015 | +481.9 pp | AMGN |
| FY2012 | +15.7 pp | AMGN |
| FY2011 | −24.9 pp | NBIX |
| FY2010 | +54.5 pp | AMGN |
The higher net margin has changed hands between AMGN and NBIX over this period.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NBIX's net margin has been more volatile than AMGN's over the 14 comparable fiscal years — 263.7 percentage points of standard deviation against 7.6.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between AMGN and NBIX over these 14 fiscal years — AMGN led in 11 and NBIX in 3.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NBIX's return on equity has been more volatile than AMGN's over the 17 comparable fiscal years — 305.5 percentage points of standard deviation against 39.3.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between AMGN and NBIX over these 17 fiscal years — AMGN led in 16 and NBIX in 1.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.